Skip Header

 

1 - 25 of 132 results for author:"Zhu B."Drop in Literature Citations

Customize display Download...

Page of 6 | Next »

The human RNA polymerase II-associated factor 1 (hPaf1): a new regulator of cell-cycle progression.

Moniaux N., Nemos C., Deb S., Zhu B., Dornreiter I., Hollingsworth M.A., Batra S.K.

PLoS ONE 4:e7077-e7077(2009) · Mapped (1)

Relationships between endothelial nitric oxide synthase gene polymorphisms and osteoporosis in postmenopausal women.

Liu S.Z., Yan H., Hou W.K., Xu P., Tian J., Tian L.F., Zhu B.F., Ma J., Lu S.M.

J Zhejiang Univ Sci B 10:609-618(2009) · Mapped (9)

CD13+CD4+CD25hi regulatory T cells exhibit higher suppressive function and increase with tumor stage in non-small cell lung cancer patients.

Ju S., Qiu H., Zhou X., Zhu B., Lv X., Huang X., Li J., Zhang Y., Liu L., Ge Y. et al.

Cell Cycle 8:2578-2585(2009) · Mapped (8)

SUN1 and SUN2 play critical but partially redundant roles in anchoring nuclei in skeletal muscle cells in mice.

Lei K., Zhang X., Ding X., Guo X., Chen M., Zhu B., Xu T., Zhuang Y., Xu R., Han M.

Proc. Natl. Acad. Sci. U.S.A. 106:10207-10212(2009) · Mapped (30)

Regulation of steroid 5-alpha reductase type 2 (Srd5a2) by sterol regulatory element binding proteins and statin.

Seo Y.K., Zhu B., Jeon T.I., Osborne T.F.

Exp. Cell Res. 315:3133-3139(2009) · Mapped (2)

Association between Bmi1 and clinicopathological status of esophageal squamous cell carcinoma.

He X.T., Cao X.F., Ji L., Zhu B., Lv J., Wang D.D., Lu P.H., Cui H.G.

World J. Gastroenterol. 15:2389-2394(2009) · Mapped (9)

Characterization of an i-type lysozyme gene from the sea cucumber Stichopus japonicus, and enzymatic and nonenzymatic antimicrobial activities of its recombinant protein.

Cong L., Yang X., Wang X., Tada M., Lu M., Liu H., Zhu B.

J. Biosci. Bioeng. 107:583-588(2009) · UniProtKB (1)

Human pancreas-specific protein disulfide isomerase homolog (PDIp) is an intracellular estrogen-binding protein that modulates estrogen levels and actions in target cells.

Fu X.M., Zhu B.T.

J. Steroid Biochem. Mol. Biol. 115:20-29(2009) · Mapped (68)

Association studies of CYP1A1 and GSTM1 polymorphisms with esophageal cancer risk: evidence-based meta-analyses.

Zhuo W.L., Zhang Y.S., Wang Y., Zhuo X.L., Zhu B., Cai L., Chen Z.T.

Arch. Med. Res. 40:169-179(2009) · Mapped (12)

Neutralization of complement regulatory proteins CD55 and CD59 augments therapeutic effect of herceptin against lung carcinoma cells.

Zhao W.P., Zhu B., Duan Y.Z., Chen Z.T.

Oncol. Rep. 21:1405-1411(2009) · Mapped (20)

Skeletal muscle growth and fiber composition in mice are regulated through the transcription factors STAT5a/b: linking growth hormone to the androgen receptor.

Klover P., Chen W., Zhu B.M., Hennighausen L.

FASEB J. 23:3140-3148(2009) · Mapped (11)

Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-{beta} and STAT3 activation.

Hosui A., Kimura A., Yamaji D., Zhu B.M., Na R., Hennighausen L.

J. Exp. Med. 206:819-831(2009) · Mapped (9)

Heterogeneous nuclear ribonucleoprotein L Is a subunit of human KMT3a/Set2 complex required for H3 Lys-36 trimethylation activity in vivo.

Yuan W., Xie J., Long C., Erdjument-Bromage H., Ding X., Zheng Y., Tempst P., Chen S., Zhu B., Reinberg D.

J. Biol. Chem. 284:15701-15707(2009) · Mapped (7)

A negative feedback regulatory loop associates the tyrosine kinase receptor ERBB2 and the transcription factor GATA4 in breast cancer cells.

Hua G., Zhu B., Rosa F., Deblon N., Adelaide J., Kahn-Perles B., Birnbaum D., Imbert J.

Mol. Cancer Res. 7:402-414(2009) · Mapped (15)

Polymorphisms of CYP1A1 and GSTM1 and laryngeal cancer risk: evidence-based meta-analyses.

Zhuo W.L., Wang Y., Zhuo X.L., Zhu B., Zhu Y., Chen Z.T.

J. Cancer Res. Clin. Oncol. 135:1081-1090(2009) · Mapped (12)

A unique insertion in the CP1 domain of Giardia lamblia leucyl-tRNA synthetase.

Zhou X.L., Yao P., Ruan L.L., Zhu B., Luo J., Qu L.H., Wang E.D.

Biochemistry 48:1340-1347(2009) · Mapped (1)

CYP1A1 and GSTM1 polymorphisms and oral cancer risk: association studies via evidence-based meta-analyses.

Zhuo W., Wang Y., Zhuo X., Zhu Y., Wang W., Zhu B., Li D., Chen Z.

Cancer Invest. 27:86-95(2009) · Mapped (2)

Identification and functional characterization of a novel cytidine deaminase in a gastropod abalone, Haliotis diversicolor supertexta.

Wu L., Wu X., Zhu B., Cao X.

Dev. Comp. Immunol. 33:709-717(2009) · UniProtKB (1)

Human pancreas-specific protein disulfide isomerase homolog (PDIp) is redox-regulated through formation of an inter-subunit disulfide bond.

Fu X., Zhu B.T.

Arch. Biochem. Biophys. 485:1-9(2009) · Mapped (7)

Inactivation of LARS2, located at the commonly deleted region 3p21.3, by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.

Zhou W., Feng X., Li H., Wang L., Zhu B., Liu W., Zhao M., Yao K., Ren C.

Acta Biochim. Biophys. Sin. (Shanghai) 41:54-62(2009) · Mapped (2)

Identification and functional analysis of a novel TRPC6 mutation associated with late onset familial focal segmental glomerulosclerosis in Chinese patients.

Zhu B., Chen N., Wang Z.H., Pan X.X., Ren H., Zhang W., Wang W.M.

Mutat. Res. 664:84-90(2009) · Mapped (2)

Cloning, Expression, and Characterization of a Novel (S)-Specific Alcohol Dehydrogenase from Lactobacillus kefir.

Chen Q., Hu Y., Zhao W., Zhu C., Zhu B.

Appl. Biochem. Biotechnol. 0:0-0(2008) · UniProtKB (1)

Enhancing SIV-specific immunity in vivo by PD-1 blockade.

Velu V., Titanji K., Zhu B., Husain S., Pladevega A., Lai L., Vanderford T.H., Chennareddi L., Silvestri G., Freeman G.J. et al.

Nature 458:206-210(2009) · UniProtKB (41)

Identification of a novel haplotype of the human catechol-O-methyltransferase gene.

Bai H.W., Zhu B.T.

Pharmacogenet. Genomics 19:87-89(2009) · Mapped (7)

Characterization of a novel human catechol-O-methyl-transferase mutant with triplet point mutations.

Bai H.W., Wang P., Zhu B.T.

Int. J. Mol. Med. 22:769-779(2008) · Mapped (7)

Page of 6 | Next »